HANNAH WANSITLER: Open Payments
NPI 1255861738 · CLIO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,329 in 81 payments from 13 companies in 2025. Trend: 2023 $240 · 2024 $310 · 2025 $1,329
Food & beverage: $1,329
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $208 |
| ABBVIE INC. | 16 | $202 |
| Novo Nordisk Inc | 15 | $174 |
| Otsuka America Pharmaceutical, Inc. | 6 | $126 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Corcept Therapeutics | 4 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $80 |
| Amgen Inc. | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $62 |
Products named: FANAPT, VRAYLAR, REXULTI, CAPLYTA, Korlym, GEMTESA, AIRSUPRA, Wegovy.
Industry payments across MI — which companies pay providers there.
